Search results
Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) After-Hours Stock ...
6 days ago · Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies.
6 days ago · Phoenix Biotech Acquisition Corp. completed the acquisition of CERo Therapeutics, Inc. Feb. 13. CI. CERo Therapeutics Holdings, Inc. announced that it has received $9.4 million in funding. Feb. 13. CI. Phoenix Biotech Acquisition Corp. Sinks 15% in Premarket Activity After Plunging 42% in Wednesday's Regular Trading.
May 9, 2024 · Ron Renaud. www.cerevel.com. Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, develops various therapies for neuroscience diseases in the United States. It is developing Emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Stock analysis for Cerevel Therapeutics Holdings Inc (CERE:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
1 day ago · CERO stock is trading at a margin of -24.18%, -43.94% and -88.07% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices. As of the close of trading, CERO deals in the Healthcare domain. The stock is trading -92.83 percent below its 52-week high and -2.13 percent above its 52-week low.
